GLP-1 therapy for women in midlife and perimenopause at Jules Inc.

THE CLINIC · PATHWAY 01 & 02

GLP-1 Therapy for Women in Midlife and Perimenopause.

GLP-1 Therapy for Women in Midlife and Perimenopause

GLP-1 Therapy for Women in Midlife and Perimenopause

Two pathways. One clinical philosophy.

GLP-1 medications have changed metabolic care for women in midlife and perimenopause. At JULES INC., they are prescribed with muscle, bone, and hormonal balance in mind, not just weight on a scale. Choose the pathway that fits your body and your goals.

PATHWAY 01

GLP-1 · Metabolic

Full-dose GLP-1 therapy for women with a clinical need for meaningful, sustained metabolic change. Prescribed by independently licensed clinicians, with clinical monitoring and integrated guidance on strength, nutrition, and recovery throughout your protocol. Compounded medication, prescribed for you individually. Not FDA-approved.

GLP-1 therapy from $249 per 4 weeks

Women pursuing meaningful weight loss, insulin regulation, or metabolic reset under clinical supervision.

Begin Metabolic Intake

PATHWAY 02

GLP-1 · Microdose

A gentler entry into GLP-1 therapy. Low-dose protocols designed for women in perimenopause who want to smooth appetite fluctuation and insulin swings without the intensity of full-dose therapy. Formulated with B12 and amino support, prescribed for you individually. Not FDA-approved.

From $179 per 4 weeks

Women not seeking major weight change, but wanting metabolic and hormonal support.

Begin Microdose Intake

GLP-1 Belongs Alongside Strength

GLP-1 Belongs Alongside Strength

The evidence is clear. If you are on a GLP-1, resistance training is essential to preserve muscle and bone. Every scaled GLP-1 clinic outsources that piece. We don’t.

Members on a JULES INC. GLP-1 protocol have access to strength classes built for perimenopause and hormonal transition, one-on-one guidance on preserving lean mass, and a community of women navigating the same protocol. The medication is one part of the plan. The rest is what makes it work.

Explore Membership

OTHER PATHWAYS

JULES INC. does not diagnose, treat, or provide medical care directly. Clinical services are delivered by independently licensed providers contracted by JULES INC. All medications are prescribed based on individual clinical evaluation. Our GLP-1 pathways use compounded medication prepared by a state-licensed compounding pharmacy for your individual prescription. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Not intended for diagnostic use.